Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | MGAM | O43451 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | SI | P14410 | 2/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.37 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL29044075 | 0.97 | FFAR3 (0.56) | FFAR3TSHRMGAMGAASI | |
| Propionic Acid SCHEMBL29044090 | 0.97 | FFAR3 (0.56) | FFAR3TSHRMGAMGAASI | |
| Propionic Acid SCHEMBL8747793 | 0.95 | FFAR3 (0.53) | FFAR3TSHRMGAMGAASI | |
| Propionic Acid SCHEMBL10936107 | 0.95 | FFAR3 (0.53) | FFAR3TSHRMGAMGAASI | |
| Bicarbonate SCHEMBL2679176 | 0.91 | TSHR (0.53) | FFAR3TSHRMGAMGAASI | |
| SCHEMBL3288569 | 0.91 | — | — | |
| SCHEMBL27583315 | 0.91 | TSHR (0.59) | FFAR3TSHRMGAMGAASI | |
| SCHEMBL15434 | 0.91 | — | — | |
| Cyclopentane SCHEMBL16054100 | 0.88 | TSHR (0.50) | FFAR3TSHRMGAMGAASI | |
| Acetic Acid SCHEMBL8976893 | 0.88 | MGAM (0.52) | FFAR3TSHRMGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4049754-B1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | MITSUBISHI CHEMICAL UK LTD (GB) | 2024-04-03 | — | — | EP | disclosed |
| CN-117043143-A | Substituted 2- (heteroaryloxyphenyl) sulfonates, salts thereof and their use as herbicides | 拜耳公司 | 2023-11-10 | — | — | CN | disclosed |
| EP-4219008-A1 | USE FOR THE TREATMENT OF AN ION EXCHANGE RESIN | Mitsubishi Chemical UK Limited (GB) | 2023-08-02 | — | — | EP | disclosed |
| EP-3862085-B1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | MITSUBISHI CHEMICAL UK LTD (GB) | 2023-06-07 | — | — | EP | disclosed |
| CN-115666242-A | Selective herbicides based on substituted isoxazoline carboxamides and metcamifen | 拜耳公司 | 2023-01-31 | — | — | CN | disclosed |
| EP-4049754-A1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | Mitsubishi Chemical UK Limited (GB) | 2022-08-31 | — | — | EP | disclosed |
| WO-2022108118-A1 | METHOD FOR PRODUCING SULFIDE-BASED SOLID ELECTROLYTE USING ESTER-BASED ORGANIC SOLVENT, AND SULFIDE-BASED SOLID ELECTROLYTE AND ALL-SOLID-STATE BATTERY MANUFACTURED BY SAID MANUFACTURING METHOD | 한국전자기술연구원 | 2022-05-27 | — | — | WO | disclosed |
| EP-2411147-B1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | MITSUBISHI CHEMICAL UK LTD (GB) | 2022-04-20 | — | — | EP | disclosed |
| CN-114072000-A | Molecules having certain pesticidal effects and intermediates, compositions and methods related thereto | 科迪华农业科技有限责任公司 | 2022-02-18 | — | — | CN | disclosed |
| EP-3862085-A1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | Mitsubishi Chemical UK Limited (GB) | 2021-08-11 | — | — | EP | disclosed |
| CN-112996393-A | Compositions comprising a pyridine carboxylate herbicide and a synthetic auxin herbicide or an auxin transport inhibitor | 科迪华农业科技有限责任公司 | 2021-06-18 | — | — | CN | disclosed |
| CN-106470968-B | Process for preparing 1,1-disubstituted ethylene monomers | 艾费尼蒂卡科技有限公司 | 2020-05-12 | — | — | CN | disclosed |
| CN-106535637-B | Molecules having certain pesticidal utility, and intermediates, compositions, and methods related thereto | 美国陶氏益农公司 | 2020-04-14 | — | — | CN | disclosed |
| US-9821304-B2 | Process for the treatment of an ion exchange resin | LUCITE INTERNATIONAL UK LIMITED (GB) | 2017-11-21 | — | — | US | disclosed |
| US-20140343176-A1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | Mitsubishi Chemical UK Limited (GB) | 2014-11-20 | — | — | US | disclosed |
| US-8835518-B2 | Process for the treatment of an ion exchange resin | LUCITE INTERNATIONAL UK LIMITED (GB) | 2014-09-16 | — | — | US | disclosed |
| US-20120059073-A1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | LUCITE INTERNATIONAL UK LIMITED (GB) | 2012-03-08 | — | — | US | disclosed |
| EP-2411147-A2 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | Lucite International UK Limited (GB) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010109244-A2 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | LUCITE INTERNATIONAL UK LIMITED (GB) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059073-A1 | PROCESS FOR THE TREATMENT OF AN ION EXCHANGE RESIN | RCOR1, RER1, DECR1 | FFAR3 322/4885TSHR 2640/4885MGAM 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.